[1] |
刘倩倩,高岩,邵凌云,等.中性粒细胞CD64在感染性疾病诊断中的应用现状[J].中华传染病杂志,2020,38(6):381-384.
|
[4] |
李蕊,常亮,李金洁,等.CD64 在危重疾病合并感染诊断中的应用进展[J].临床检验杂志,2019,37(7):531-534.
|
[2] |
Liu Q,Gao Y,Ou Q,et al.Differential expression of CD64 in patients with Mycobacterium tuberculosis infection:A potential biomarker for clinical diagnosis and prognosis[J].J Cell Mol Med,2020,24(23):13 961-13 972.
|
[3] |
Patnaik R,Azim A,Agarwal V.Neutrophil CD64 a Diagnostic and Prognostic Marker of Sepsis in Adult Critically Ill Patients:A Brief Review[J].Indian J Crit Care Med,2020,24(12):1242-1250.
|
[5] |
Yeh CF,Wu CC,Liu SH,et al.Comparison of the accuracy of neutrophil CD64,procalcitonin,and C-reactive protein for sepsis identification:a systematic review and meta-analysis[J].Ann Intensive Care,2019,9(1):5.
|
[6] |
Cui W,Xu Y,Fang H,et al.Assessment of continuous neutrophil CD64 index measurement for diagnosing sepsis and predicting outcome in a Chinese pediatric intensive care unit:a prospective study[J].Transl Pediatr,2021,10(6):1668-1676.
|
[7] |
Jämsä J,Ala-Kokko T,Huotari V,et al.Neutrophil CD64,C-reactive protein,and procalcitonin in the identification of sepsis in the ICU-Post-test probabilities[J].J Crit Care,2018,43:139-142.
|
[8] |
Zhou Y,Zhang Y,Johnson A,et al.Combined CD25,CD64,and CD69 biomarker panel for flow cytometry diagnosis of sepsis[J].Talanta,2019,191:216-221.
|
[9] |
Goswami DG,Garcia LF,Dodoo C,et al.Evaluating the Timeliness and Specificity of CD69,CD64 and CD25 as Biomarkers of Sepsis in MICE[J].Shock,2021,55(4):507-518.
|
[10] |
Inoue S,Ikeda H.Differences in plasma amino acid levels in patients with and without bacterial infection during the early stage of acute exacerbation of COPD[J].Int J Chron Obstruct Pulmon Dis,2019,14:575-583.
|
[11] |
Hassan NB,Abo-ElMagd NM,Ahmed NO.Neutrophil CD64 Expression and other Laboratory Biomarkers in Discriminating Bacterial versus Non Bacterial Acute Exacerbation Chronic Obstructive Pulmonary Disease[J].Egypt J Immunol,2018,25(1):171-179.
|
[12] |
Xu N,Chen J,Chang X,et al.nCD64 index as a prognostic biomarker for mortality in acute exacerbation of chronic obstructive pulmonary disease[J].Ann Saudi Med,2016,36(1):37-41.
|
[13] |
Qian W,Huang GZ.Neutrophil CD64 as a Marker of Bacterial Infection in Acute Exacerbations of Chronic Obstructive Pulmonary Disease[J].Immunol Invest,2016,45(6):490-503.
|
[14] |
周峰,杨佳其,陈全敏,等.外周血CD64 指数、C反应蛋白及降钙素原对慢性阻塞性肺疾病急性加重期合并细菌感染的诊断及临床治疗价值分析[J].实用医院临床杂志,2020,17(5):44-47.
|
[15] |
Brooks WA,Zaman K,Goswami D,et al.The Etiology of Childhood Pneumonia in Bangladesh:Findings From the Pneumonia Etiology Research for Child Health(PERCH)Study[J].Pediatr Infect Dis J,2021,40(9S):S79-S90.
|
[16] |
García-Salido A,de Azagra-Garde AM,García-Teresa MA,et al.Accuracy of CD64 expression on neutrophils and monocytes in bacterial infection diagnosis at pediatric intensive care admission[J].Eur J Clin Microbiol Infect Dis,2019,38(6):1079-1085.
|
[19] |
文福生,张必旗,常佳军.多指标联合检测在小儿细菌性肺炎病原学诊断中的应用[J].中华实验和临床感染病杂志(电子版),2020,14(5):418-423.
|
[27] |
彭莉.血清PCT、CD64、hs-CRP 在检测早产儿败血症感染中的应用价值[J].黑龙江医药,2020,33(4):937-939.
|
[28] |
Goswami S,Gupta R,Ramji S.Flow Cytometry:An Important Diagnostic Tool in Critically Ill Preterm Neonates with Suspected Sepsis[J].Am J Perinatol,2020,29:1.
|
[17] |
Thiriet C,Mahjoub K,Courte G,et al.Automated measurement of neutrophil CD64 expression for diagnosing sepsis in critically ill patients[J].Minerva Anestesiol,2019,85(9):943-950.
|
[18] |
Yin WP,Li JB,Zheng XF,et al.Effect of neutrophil CD64 for diagnosing sepsis in emergency department[J].World J Emerg Med,2020,11(2):79-86.
|
[20] |
Zhong MF,Zhao JM.Diagnostic values of plasma CD64 and sTREM-1 for pediatric pneumonia[J].Zhongguo Dang Dai Er Ke Za Zhi,2016,18(7):599-602.
|
[21] |
Hume-Nixon M,Quach A,Reyburn R,et al.A Systematic Review and meta-analysis of the effect of administration of azithromycin during pregnancy on perinatal and neonatal outcomes[J].E Clin Med,2021,40:101123.
|
[22] |
Memar MY,Alizadeh N,Varshochi M,et al.Immunologic biomarkers for diagnostic of early-onset neonatal sepsis[J].J Matern Fetal Neonatal Med,2019,32(1):143-153.
|
[23] |
Hung SK,Lan HM,Han ST,et al.Current Evidence and Limitation of Biomarkers for Detecting Sepsis and Systemic Infection[J].Biomedicines,2020,8(11):494.
|
[24] |
Miyake F,Ishii M,Hoshina T,et al.Analysis of the Physiological Variation in Neutrophil CD64 Expression during the Early Neonatal Period[J].Am J Perinatol,2016,33(14):1377-1381.
|
[25] |
Tang Z,Qin D,Tao M,et al.Examining the utility of the CD64 index compared with other conventional indices for early diagnosis of neonatal infection[J].Sci Rep,2018,8(1):9994.
|
[26] |
Qin DJ,Tang ZS,Chen SL,et al.Value of combined determination of neutrophil CD64 and procalcitonin in early diagnosis of neonatal bacterial infection[J].Zhongguo Dang Dai Er Ke Za Zhi,2017,19(8):872-876.
|
[29] |
ELMeneza S,Mohamed W,Elbagoury I,et al.Role of neutrophil CD11b expression in diagnosis of earlyonset neonatal sepsis in full-term infant[J].Clin Exp Pediatr,2021,64(1):44-45.
|
[30] |
Katoh N,Nishino J,Nishimura K,et al.Normal sequential changes in neutrophil CD64 expression after total joint arthroplasty[J].J Orthop Sci,2013,18(6):949-954.
|
[31] |
Achkasov SI,Sukhina MA,Sushkov OI,et al.The role of neutrophil CD64 index in the diagnosis of infectious complications after colorectal resection[J].Khirurgiia(Mosk),2020,(10):29-35.
|
[32] |
Qu PF,Li R,Xu C,et al.A Clinical Pilot Study to Evaluate CD64 Expression on Blood Monocytes as an Indicator of Periprosthetic Joint Infection[J].J Bone Joint Surg Am,2020,102(17):e99.
|
[33] |
Qin L,Hu N,Li X,et al.Evaluation of synovial fluid neutrophil CD64 index as a screening biomarker of prosthetic joint infection[J].Bone Joint J,2020,102-B(4):463-469.
|
[34] |
刘仁德,蔡广荣,罗斯敏,等.血清CD64、VEGF、SDF-1对监测开放性骨折术后感染的价值[J].中国矫形外科杂志,2020,28(14):1273-1277.
|
[35] |
林哲,王丹丹,曾永婷.CD64 联合SAA、CRP 诊断老年颅脑手术患者颅内感染的临床价值[J].中国老年学杂志,2020,40(16):3487-3490.
|